FDA Commissioner nominee Robert Califf suggests reforming the clinical trials system so that a combination of small, focused trials for precision medicine and very large trials using electronic health records can be conducted at a lower cost and provide information about benefits and risks of therapeutic interventions to specific patients and populations, responding to inquiries from Senate health committee Chair Lamar Alexander (R-TN) and ranking Democrat Patty Murray (WA). Califf, whose nomination will be voted on Tuesday (Jan. 12), also...
You've followed a link to an article or document on InsideHealthPolicy.com.
There are two ways you can access this content.
Subscriber Login
If you are an InsideHealthPolicy.com subscriber, or you have an active trial subscription, please login here:
Take A Trial Subscription
If you haven't already had a trial subscription to InsideHealthPolicy.com, you can sign up for one right now. Just click on the link below to get started -- you'll get full access for one month, including access to our newsletters, Inside CMS and FDA Week, plus daily news updates by e-mail and much, much more.
Sign up for a trial subscription.